<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Galderma Group AG 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=47554></link><description><![CDATA[Galderma Group AG 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 13 May 2026 13:56:30 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/03/12_1028147215_20250314152434_4809441958.png]]></url></image><language>ko-KR</language><item><title><![CDATA[Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1033015</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026.  · Strong start to the year delivering net sales of 1,473 million USD, predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique,...]]></description><pubDate>Thu, 23 Apr 2026 16:33:10 +0900</pubDate></item><item><title><![CDATA[Galderma Shareholders Approve All Annual General Meeting Proposals]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1033009</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), held earlier today via live webcast. This includes the payment of a gross dividend of 0.35 CHF per dividend-bearing share[1], to be distributed out ...]]></description><pubDate>Thu, 23 Apr 2026 15:51:39 +0900</pubDate></item><item><title><![CDATA[Galderma Completes Successful Placement of EUR 500 Million Eurobond]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1030101</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SWX:GALD):  NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION.  Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche EUR 500 million Eurobond. The ...]]></description><pubDate>Wed, 11 Mar 2026 15:52:19 +0900</pubDate></item><item><title><![CDATA[Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency, and Core EBITDA of 1.211 billion USD, Growing 18.9% at Constant Currency]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1029759</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025.  · Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency[1] basis, primarily driven by volume. · Broad-base...]]></description><pubDate>Thu, 05 Mar 2026 16:04:35 +0900</pubDate></item><item><title><![CDATA[Galderma Welcomes Increased Equity Investment From L’Oréal]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1024862</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers).  Fo...]]></description><pubDate>Mon, 08 Dec 2025 15:12:58 +0900</pubDate></item><item><title><![CDATA[Galderma Completes Successful Placement of CHF 175 Million Bond]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1023070</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION.  Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a ...]]></description><pubDate>Fri, 14 Nov 2025 15:10:11 +0900</pubDate></item><item><title><![CDATA[Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1022288</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for augmentation of the chin region to improve the chin profile in patients over the age of 21 with mild-to-moderate chin retrusion.[2] Restylane Lyft is a ve...]]></description><pubDate>Wed, 05 Nov 2025 16:10:00 +0900</pubDate></item><item><title><![CDATA[Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1021275</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commercial and innovation momentum across its portfolio.  ·Record net sales of 3.737 billion USD for the first nine months of the year, representing net sa...]]></description><pubDate>Thu, 23 Oct 2025 16:58:27 +0900</pubDate></item><item><title><![CDATA[Galderma Announces Departure of Its Chief Financial Officer]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1014132</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization.  “We thank Thomas for his financial leadership and many contributions during his time at Galderma. He played a...]]></description><pubDate>Tue, 01 Jul 2025 14:13:00 +0900</pubDate></item><item><title><![CDATA[Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1012009</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SWX:GALD):  Ad hoc announcement pursuant to Art. 53 LR  · Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today · The...]]></description><pubDate>Wed, 28 May 2025 09:05:58 +0900</pubDate></item><item><title><![CDATA[Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1010031</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025.  · Net sales: Achieved 1,129 million USD in net sales, up 8.3% year-on-year on a constant currency basis, primarily driven by volume, complemented by favorable mix · Results ahead of expectations: Net sale...]]></description><pubDate>Thu, 24 Apr 2025 14:15:25 +0900</pubDate></item><item><title><![CDATA[Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1009632</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their latest skincare innovation with the introduction of Restorative Skin Complex with Next Generation TriHex Technology® (TriHex+™). This newly enhanced fo...]]></description><pubDate>Thu, 17 Apr 2025 16:39:07 +0900</pubDate></item><item><title><![CDATA[Galderma Successfully Placed an Inaugural EUR 500 Million Single Tranche Eurobond and New Dual Tranche CHF 435 Million CHF Bonds]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1007555</link><description><![CDATA[ZUG, Switzerland--(Business Wire/Korea Newswire)--Galderma Group AG (SWX:GALD):  NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION.  Galderma (SIX: GALD) has made significant progress on its refinancing strategy to spread out its maturity profile, diversify funding sources and reduce its interest...]]></description><pubDate>Fri, 14 Mar 2025 15:32:48 +0900</pubDate></item></channel></rss>